1
|
Adorisio R, Ingrasciotta G, Ionata A, Cantarutti N, Bellettini E, Mencarelli E, Pilati M, Kirk R, Amodeo A. Endomyocardial Biopsy in Myocarditis Identifies Factors That Predict Outcome in Children. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
2
|
Adorisio R, Cantarutti N, Bellettini E, Ingrasciotta G, Mencarelli E, Grandinetti M, Kirk R, Amodeo A. Combined Strategy to Induce Myocardial Recovery in Children with Advanced Heart Failure: Single Center Retrospective Study. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Graziani F, Cialdella P, Lillo R, Locorotondo G, Genuardi L, Ingrasciotta G, Nesta ML, Bruno P, Aurigemma C, Romagnoli E, Calabrese M, Giambusso N, Lombardo A, Burzotta F, Trani C. Acute hemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background. There are limited data about the intraprocedural hemodynamic study performed immediately before and after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis (AS). Purpose. We aimed to evaluate the acute hemodynamic impact of TAVI in patients with severe AS and to investigate invasive and non-invasive parameters predicting all-cause mortality. Methods. A total of 245 consecutive AS patients undergoing TAVI were enrolled. Intraprocedural left heart catheterization (LHC) and echocardiogram before and after TAVI were performed. The clinical endpoint was the death for any cause. Results. LHC after TAVI revealed significant changes in aortic and LV pressures, including indexes of intrinsic myocardial contractility and diastolic function such as positive dP/dT (1128.9 ± 398.7 vs 806.3 ± 247.2 mmHg/sec, p˂0.001; Figure 1A) and negative dP/dT (1310.7± 431.1 vs 1075.1 ± 440.8 mmHg/sec, p˂0.001; Figure 1B). Post TAVI echo showed a significant reduction in LV end diastolic volume index (54.6 ± 18.4 ml/m2 vs 51.7 ± 17.5 ml/m2; p = 0.017; Figure 1C), improvement in left ventricle ejection fraction (from 55 ± 12 to 57.2 ± 10.5%, p˂0.001; Figure 1D) and pulmonary artery systolic pressure (42.1 ± 14.2 vs 33.1 ± 10.7 mmHg, p < 0.001; Figure 1E). After a mean follow-up time interval of 24 months, 47 patients died. Post-TAVI aortic regurgitation (2- 3- 4+) at echocardiography was the only independent predictor of mortality (HR 4.43, C.I. 1,71 – 11,45, p = 0.002; Figure 2). Conclusions. LHC performed immediately before and after prosthesis release offers a unique insight in the assessment ofLV adaptation to severe AS and the impact of TAVI on LV, catching changes in indexes of intrinsic contractility and myocardial relaxation. Aortic regurgitation assessed by echocardiography was the only independent predictor of mortality in patients undergoing TAVI.
FIGURE LEGEND
Figure 1. A-B: Impact of TAVI on haemodynamic parameters: Box plot with median and interquartile ranges of positive dP/dT and negative dP/dT values pre vs post TAVI. C-D-E: Impact of TAVI on echocardiographic parameters: Box plot with median and interquartile ranges of left ventricular end diastolic volume index (LVEDVi), left ventricular ejection fraction (EF) and pulmonary artery systolic pressure (PASP) values pre vs post TAVI.
Figure 2. Kaplan-Meier curves for survival showing that AR (2-3-4+) assessed with echocardiography had the strongest association with mortality. Abstract Figure 1. Abstract Figure 2.
Collapse
Affiliation(s)
- F Graziani
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - P Cialdella
- Catholic University of the Sacred Heart, Rome, Italy
| | - R Lillo
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - G Locorotondo
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - L Genuardi
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - G Ingrasciotta
- Catholic University of the Sacred Heart - Fondazione Policlinico Universitario A. Gemelli IRCCS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - ML Nesta
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - P Bruno
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - C Aurigemma
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - E Romagnoli
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - M Calabrese
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - N Giambusso
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - A Lombardo
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - F Burzotta
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| | - C Trani
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences,, Rome, Italy
| |
Collapse
|
4
|
Graziani F, Lillo R, Leccisotti L, Bruno I, Ingrasciotta G, Marano R, Rovere G, Manna R, Pieroni M, Camporeale A, Lanza GA, Crea F. The presence and extent of coronary microvascular dysfunction is associated to the severity of cardiomyopathy in patients with Fabry disease. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Coronary microvascular dysfunction (CMD) occurs before left ventricular hypertrophy (LVH) in Anderson Fabry Disease (AFD). Few data exist about the role of CMD in Fabry cardiomyopathy, when overt LVH has already established.
Purpose
Aim of our study was to assess the relationship between CMD and clinical and echocardiographic features in a cohort of Fabry cardiomyopathy patients.
Methods
We performed coronary CT scan to exclude epicardial coronary artery disease (CAD) in 27 AFD cardiomyopathy patients with angina and/or evidence of silent ischemia at treadmill stress test. All consenting patients with no CAD (n = 17) were submitted to resting and stress 13N-Ammonia myocardial perfusion PET/CT to assess the presence of CMD. All patients also underwent complete echocardiography. Patients were followed-up for 17.3 ± 12.5 months.
Results
Global coronary flow reserve (CFR) resulted <2.5 in 7 (41%) patients. Global stress myocardial blood flow (MBF) was <1.85 mL/min/g in 5 (29%) patients. Global transmural perfusion gradient (TPG, subendocardial MBF/subepicardial MBF) during stress was <1.0 in 13/17 (76.5%) patients. Resting global TPG was ≥1 in 16 (94%) patients. Patients with CFR < 2.5 were older (p = 0.02), had more severe LVH (maximal wall thickness p = 0.04), worst global longitudinal strain (p = 0.03) and E/e’ (p = 0.04) and higher troponin levels (p = 0.002) as compared to patients with CFR ≥ 2.5. They also performed less at treadmill stress (METs p = 0.045). No variables were associated to major cardiovascular events at multivariable analysis.
Conclusions
In Fabry cardiomyopathy patients with angina and/or evidence of silent ischemia, the prevalence of CMD is high and it is associated to a more severe cardiac phenotype, including cardiac biomarker and functional capacity. We are not able to draw any conclusion on the possible prognostic role of CMD in Fabry cardiomyopathy.
Collapse
Affiliation(s)
- F Graziani
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Cardiovascular and Thoracic Sciences, Rome, Italy
| | - R Lillo
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Emergency Medicine Department, Rome, Italy
| | - L Leccisotti
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Nuclear Medicine Unit, Rome, Italy
| | - I Bruno
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Nuclear Medicine Unit, Rome, Italy
| | - G Ingrasciotta
- Catholic University of the Sacred Heart, Department of Cardiovascular and Thoracic Sciences, Rome, Italy
| | - R Marano
- Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Department of Radiological and Hematological Sciences, Section of Radiology, Rome, Italy
| | - G Rovere
- Fondazione Policlinico Universitario A. Gemelli IRCSS, Department of Radiological and Hematological Sciences, Section of Radiology, Rome, Italy
| | - R Manna
- Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Department of Internal Medicine, Rare Diseases and Periodic Fevers Research Centre, Rome, Italy
| | - M Pieroni
- San Donato Hospital of Arezzo, Cardiovascular Department, Arezzo, Italy
| | - A Camporeale
- IRCCS Policlinico San Donato, Multimodality Cardiac Imaging Unit, San Donato Milanese, Italy
| | - GA Lanza
- Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Department of Cardiovascular and Thoracic Sciences, Rome, Italy
| | - F Crea
- Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Department of Cardiovascular and Thoracic Sciences, Rome, Italy
| |
Collapse
|
5
|
Manfredonia L, Locorotondo G, Graziani F, Ravenna SE, Ruscio E, Filice M, Ingrasciotta G, Palma F, Addamo E, Lombardo A, Lanza GA, Crea F. P1590 Regional differences in longitudinal strain and response to adenosine stress in patients with myocardial infarction and ST-segment elevation. Results from Extreme trial. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.1010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Global longitudinal strain (LS) is a sensitive marker of ischemic myocardial damage and predicts adverse left ventricular (LV) remodeling and outcome, independently of infarct size. In healthy subjects, regional LS increases from LV base to apex and enhances under physical or pharmacological stress, while in ST-elevation myocardial infarction (STEMI), response to dobutamine depends on transmurality of necrosis. It is known that coronary flow reserve during adenosine (ADN) is impaired both in ischemic and remote myocardium, but effect of ADN on strain reserve has never been investigated. Similarly, LS response to ADN in ischemic (iLS) and remote (rLS) myocardium and their relative contribution to LV function and remodeling are still unknown.
Methods
61 consecutive patients with first STEMI (26 anterior, 29 inferior, 6 lateral), treated by successful primary percutaneous coronary intervention (PCI) followed by PCI of non-culprit coronary arteries, underwent rest and stress ADN (140 mcg/kg/minutes in 90 seconds) echocardiography at discharge (7 ± 2 days after admission). LV end-diastolic volume indexed for body surface area (EDV), ejection fraction (EF) and wall motion score index (WMSI) were measured at rest, while GLS, iLS and rLS analysis was performed both at rest and during stress. Ischemic and remote myocardium was allocated, by standard LV segmentation, basing on the culprit coronary artery.
Results
Significant differences existed among anterior, inferior and lateral STEMI in median (iQr) EDV [52 (45-59) vs 45 (36-51) vs 48 (45–56) ml, respectively, p=.034 overall], EF [47 (37-58) vs 58 (53–61) vs 56 (46-60)%, respectively, p=.002 overall], WMSI [1.63 (1.38–2) vs 1.25 (1.19-1.47) vs 1.41 (1.30-1.75), respectively, p=.001 overall]. GLS differed among anterior, inferior and lateral STEMI both at rest [13.75 (11.63-16.1) vs 19.5 (17.15-22.4) vs 17.85 (17.02-19), respectively, p<.001 overall] and during ADN [14 (12.35-16.15) vs 19.5 (17.9–22.05) vs 15.95 (14.40-19.48), respectively, p<.001], but did not change within groups. No differences were found between rest and stress iLS in any group. Similarly, rLS remained unchanged in anterior and inferior STEMI, and impaired after ADN in lateral STEMI [15.90 (11.45-18) at stress vs 16.8 (15.25-19.2) at rest, p=.043]. Inferior STEMI showed better iLS than anterior STEMI both at rest [17 (15.1–19.9) vs 13.75 (11.46-16.92), respectively, p=.001] and during stress [16.2 (15–20.4) vs 14.42 (12.67-15.83), respectively, p=.001].
Conclusions
In the subacute phase of STEMI, GLS, iLS and rLS are heterogeneous and depend on infarct site. After ADN, there is no strain reserve in ischemic neither in remote myocardium. This may reflect regional differences in the response of microcirculation and myocardium to ischemia or may underlie pre-existing pathophysiological differences in the coronary circulation
Collapse
Affiliation(s)
- L Manfredonia
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - G Locorotondo
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - F Graziani
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - S E Ravenna
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - E Ruscio
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - M Filice
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - G Ingrasciotta
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - F Palma
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - E Addamo
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - A Lombardo
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - G A Lanza
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| | - F Crea
- Fondazione Policlinico Univesitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Institute of Cardiology, Rome, Italy
| |
Collapse
|